RxDoctor Payments Data

Kim Isaacs, MD

Gastroenterology · Chapel Hill, NCNPI 1164591418

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,216 of the $13,483 with a category attached, or 98.0%. Janssen Research & Development, LLC accounts for 98.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $5,818 and has fallen 97.2% since, to $160 in 2022.

$13,483in general payments, 2019–2025

Across 13 payments — averaging $1037.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$13K
  • Takeda Pharmaceuticals U.S.A., Inc.$108
  • Steris Corporation$101
  • Covidien LP$25
  • AbbVie$22
  • Hologic Sales And Service, LLC$11
$734,150in research payments, 2019–2025

Across 166 payments — averaging $4422.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$169K
  • Takeda Pharmaceuticals U.S.A., Inc.$140K
  • Eli Lilly$125K
  • Roche Products Limited$114K
  • AbbVie$94K
  • UCB Biosciences Inc.$59K
  • plus $32K from 1 others

What the payments were for

  • Consulting fees$13,21698%
  • Food & beverage$2672%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,483 in reported general payments places this provider in the 85th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina

Medicare billing

Part B allowed, 2024
$24,583
Medicare patients
127
Services billed
161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →